Leerink Partners Reiterates a Buy Rating on Ardent Health Partners (ARDT)

Ardent Health Partners, Inc. (NYSE:ARDT) is one of the 13 Cheap Healthcare Stocks with Huge Upside Potential. Leerink Partners analyst Whit Mayo reiterated a Buy rating on Ardent Health Partners, Inc. (NYSE:ARDT) on July 5 without a price target.

15 Healthiest Countries In Africa

A healthcare professional wearing a health communications device discussing patient data with a colleague.

The rating continued the analyst’s bullish streak on the company, as he gave it a buy rating on June 23 due to strong sector trends and the belief that the company is presently underperforming its potential. The analyst stated that Ardent Health Partners, Inc. has a strong outpatient network strategy with potential for growth.

Mayo further reasoned that despite the delay in the anticipated $65 million NM DPP contribution to Q3 2025, the company’s full-year EBITDA remains unaffected, attributing the delay to uncertainty in the timing of CMS approval instead of a lack of confidence in the eventual approval.

Ardent Health Partners, Inc. is a provider of healthcare and related services. The company is headquartered in Brentwood, TN, and also owns and operates hospitals through its subsidiaries.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

This article is originally published at Insider Monkey.